Nicholas Vardy
Back in the Air with This Sky High Pick and Booking 130% Option Gains
This week’s Alpha Algorithm recommendation returns us to The Boeing Company (BA) — one of the world’s major aerospace firms. Recall that you were stopped out of Boeing (BA) on Aug. 9 at $234.30 for a 25.78% gain. Founded over a century ago in 1916 and based in Chicago, the company operates in three principal segments: […]
VIP Alliance Weekly Update
I. Conservative Recommendation Visa (V) Visa is a current recommendation in my weekly trading service, Alpha Algorithm. Recently, Visa reported third-quarter fiscal 2017 (ended June 30, 2017) earnings of $0.86 per share, beating consensus estimates of $0.80. Overall, earnings improved 25% year over year. Visa’s growth has been driven by the acquisition of Visa Europe, […]
Pabrai’s Pick Continues to Soar
All major U.S. stock market averages ended the week lower for the second time in a row. The S&P 500 fell 0.43% and the Dow Jones dropped 0.51%. The tech-heavy Nasdaq pulled back 0.68%. In contrast, the MSCI Emerging Markets recovered a solid 2.10%. The star of your Smart Money Masters holdings was, yet again, your […]
This Buffett Disciple’s Biggest Bet Is Soaring
International investment expert Nicholas Vardy shares the details to a Buffett disciple’s biggest bet.
A Momentum Play South of the Border — and Booking Three Double-Digit Option Gains
This week’s Momentum Trader Alert recommendation comes from Mexico, the fifth best-performing stock market of 2017 from among the 47 global markets I track around the world on a daily basis. Mexico’s performance this year may come as a big surprise given the negative market sentiment that surrounded Mexico and its economy following the election […]
The Alpha Algorithm Goes Back Into Biotech
This week’s Alpha Algorithm recommendation returns you to a sector that has been out of favor over the past 12 months with biotech giant Gilead Sciences Inc. (GILD). Founded in 1987 and headquartered in Foster City, California, Gilead Sciences, Inc. is an independent biotech company that has a broad-based focus on developing and marketing drugs […]